Virtus ETF Advisers’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,183
| Closed | -$72.8K | – | 522 |
|
|
2024
Q4 | $72.8K | Buy |
3,183
+989
| +45% | +$22.6K | 0.03% | 354 |
|
|
2024
Q3 | $92.1K | Buy |
2,194
+38
| +2% | +$1.59K | 0.04% | 388 |
|
|
2024
Q2 | $78.5K | Buy |
+2,156
| New | +$78.5K | 0.04% | 411 |
|
|
2017
Q4 | – | Sell |
-1,193
| Closed | -$339K | – | 257 |
|
|
2017
Q3 | $339K | Buy |
1,193
+109
| +10% | +$31K | 0.05% | 126 |
|
|
2017
Q2 | $305K | Buy |
1,084
+180
| +20% | +$50.6K | 0.05% | 118 |
|
|
2017
Q1 | $302K | Buy |
904
+87
| +11% | +$29.1K | 0.05% | 134 |
|
|
2016
Q4 | $270K | Buy |
+817
| New | +$270K | 0.08% | 121 |
|